The diagnosis and treatment of invasive breast cancer requires a collaborative effort among
multiple subspecialties. Diagnostic imaging workup and biopsy play a key role in …

Abstract Purpose of Review Obesity is a recognized risk factor for the development of breast
cancer and recurrence even when patients are treated appropriately. We reviewed the …

Accurate identification of axillary lymph node (ALN) involvement in patients with early-stage
breast cancer is important for determining appropriate axillary treatment options and …

Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial
comparing disease-free survival in patients with breast cancer with one or more …

Axillary lymph node (LN) metastasis is the most important predictor of overall recurrence and
survival in patients with breast cancer, and accurate assessment of axillary LN involvement …

Breast cancer-related lymphedema (BCRL) is a negative sequela of breast cancer
treatment, and well-established risk factors include axillary lymph node dissection (ALND) …

Background For patients with breast cancer and metastases in the sentinel nodes, axillary
dissection has been standard treatment. However, for patients with limited sentinel-node …

Purpose GANEA2 study was designed to assess accuracy and safety of sentinel lymph node
(SLN) after neo-adjuvant chemotherapy (NAC) in breast cancer patients. Methods Early …

Breast cancer is the most common malignancy in women in the United States and is second
only to lung cancer as a cause of cancer death. The overall management of breast cancer …

Background Although numerous studies have shown that the status of the sentinel node is
an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and …